# Neuphoria Therapeutics Inc. (NEUP) FY2026 Annual P&L / Income Statement

- Company: Neuphoria Therapeutics Inc. (NEUP)
- Period: 2025-07-01 to 2026-06-30
- Filing: FY2026 10-K, filed 2026-09-18, accession number 0001193125-26-395536
- Page: https://plicit.ai/financials/neup/fy2026-annual-income-statement
- Chart image: https://plicit.ai/charts/neup-fy2026-annual-income-statement-sankey.png

## Chart details

Income statement for 2025-07-01 through 2026-06-30. Consolidated revenue, costs and expenses.

- **Total revenue**: 1,174,165 US dollars
- **Total operating expenses**: 17,625,231 US dollars
- **Loss from operations**: negative 16,451,066 US dollars
- **Total other income**: 2,859,962 US dollars
- **Loss before income taxes**: negative 13,591,104 US dollars
- **Income tax benefit**: negative 139,173 US dollars
- **Net loss**: negative 13,451,931 US dollars
- **Total operating expenses**: 17,625,231 US dollars

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.